Brookline Capital raises Kymera Therapeutics price target on reduced risk
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Finance & Markets
Postmedia to Extend Maturity and Reduce the Interest Rate of its Second Lien Notes
TORONTO — Postmedia Network Canada Corp. (“Postmedia” or the “Company”) announced today that it has entered into a definitive agreement with Chatham Asset Management and its affiliates (collectively…
XPO Q3 revenue rises 12% as focus on higher-margin freight pays off
Chairman and CEO Mario Harik said the LTL carrier has been seeking to grow its premium services and is testing new verticals, like healthcare and grocery consolidation.
Another green day on local markets
Nick Kunze of Sanlam Private Wealth unpacks gains on the JSE, US interest rates, concerns over technology companies’ capital expenditure. He also examines movements in Brent crude as shipping traffic through the Strait of Hormuz increases, and the potential impact of elections on the rand.